Artificial selection for host resistance to tumour growth and subsequent cancer cell adaptations: an evolutionary arms race.

Host species can rapidly evolve both immunologic and non-immunologic tumour defences. However, cancer cell plasticity allows effective phenotypic and population-based counter strategies.